A Study of the Onset and Offset of Antiplatelet Effects Comparing Ticagrelor, Clopidogrel, and Placebo With Aspirin
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
9 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Research Site
Sheffield, United Kingdom
- Research Site
Baton Rouge, Louisiana, United States
- Research Site
Baltimore, Maryland, United States
- Research Site
Towson, Maryland, United States
- Research Site
Cincinnati, Ohio, United States
- Research Site
Oklahoma City, Oklahoma, United States
- Research Site
Philadelphia, Pennsylvania, United States
- Research Site
Rapid City, South Dakota, United States
- Research Site
Houston, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Oct 2007
- Primary completion
- 31 Mar 2009
- Completion
- 31 Mar 2009
- Last update posted
- 13 Jan 2012
- Registered enrollment
- 123
- Registry id
- NCT00528411
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.